Benzinga - by Avi Kapoor, Benzinga Staff Writer.
Shares of Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) rose sharply during Tuesday’s session after the company released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of Developmental and Epileptic Encephalopathies (DEEs).
Longboard Pharmaceuticals shares jumped 199.7% to $18.07 on Tuesday.
Here are some other stocks moving in today's mid-day session.
Gainers
- Akso Health Group (NASDAQ: AHG) surged 85% to $1.2946.
- Polished.com Inc. (NYSE: POL) gained 45% to $8.77.
- Dogness (International) Corporation (NASDAQ: DOGZ) jumped 40% to $7.42.
- Cue Health Inc. (NASDAQ: HLTH) gained 36.8% to $0.2224 after falling 42% on Friday.
- Voyager Therapeutics, Inc. (NASDAQ: VYGR) surged 34% to $11.38 after the company announced a strategic collaboration and capsid license agreement with Novartis to advance potential gene therapies for Huntington's disease and spinal muscular atrophy.
- RiskOn International, Inc. (NASDAQ: ROI) shares climbed 33.5% to $0.4450 after gaining around 17% on Friday. RiskOn International recently said it expects to announce its new generative AI platform and unveil a principal technology partner on Jan. 3.
- Soligenix, Inc. (NASDAQ: SNGX) shares gained 33.4% to $1.01. Soligenix announced publication demonstrating complete protection against filovirus disease in nonhuman primate models of ebola and marburg viruses.
- SenesTech, Inc. (NASDAQ: SNES) gained 22.2% to $1.56. SenesTech announced the expansion of its distribution agreement with Pesterminators Pvt Ltd to include the deployment of EvolveTM.
- Brooge Energy Limited (NASDAQ: BROG) jumped 17.1% to $4.31. Brooge Energy recently announced that it reached a settlement with the SEC where it agreed to pay a $5 million penalty and cease any future violations.
- Lyell Immunopharma, Inc. (NASDAQ: LYEL) gained 16.9% to $2.26.
- Wheels Up Experience Inc. (NYSE: UP) surged 16.9% to $4.01.
- BTCS Inc. (NASDAQ: BTCS) shares rose 14.1% to $1.8593 amid strength in Bitcoin.
- Allogene Therapeutics, Inc. (NASDAQ: ALLO) gained 12% to $3.59.
- Precigen, Inc. (NASDAQ: PGEN) rose 11.9% to $1.50.
- Argo Blockchain plc (NASDAQ: ARBK) shares gained 11.8% to $4.18 after falling 8% on Friday.
- MicroStrategy Incorporated (NASDAQ: MSTR) gained 11.4% to $703.40 after Bitcoin rose above $45,000.
- Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) rose 10.8% to $19.43.
- MannKind Corporation (NASDAQ: MNKD) gained 9.9% to $4.0001. MannKind sold a 1% royalty in net sales of Tyvaso DPI (Treprostinil) inhalation powder in exchange for up to $200 million, including the purchase price of $150 million and an additional potential milestone payment of up to $50 million.
- Moderna, Inc. (NASDAQ: MRNA) climbed 9.8% to $109.18 after Openheimer upgraded the stock from Perform to Outperform.
- Alpha and Omega Semiconductor Limited (NASDAQ: AOSL) gained 8.8% to $28.36. B. Riley Securities analyst Craig Ellis upgraded Alpha & Omega from Neutral to Buy and raised the price target from $28 to $34.
- Hut 8 Corp. (NASDAQ: HUT) gained 6.3% to $14.19 amid strength in Bitcoin.
- CleanSpark, Inc. (NASDAQ: CLSK) gained 6.2% to $11.71 amid strength in Bitcoin.
- Marathon Digital Holdings, Inc. (NASDAQ: MARA) shares jumped 6% to $24.88 amid strength in Bitcoin.
- Riot Platforms, Inc. (NASDAQ: RIOT) surged 5.3% to $16.29 mid strength in Bitcoin.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- RenovoRx, Inc. (NASDAQ: RNXT) shares tumbled 29.9% to $1.6050.
- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) fell 28.8% to $2.8250 after gaining 92% on Friday.
- Sentage Holdings Inc. (NASDAQ: SNTG) shares fell 28.8% to $3.56 after jumping over 182% on Friday.
- LumiraDx Limited (NASDAQ: LMDX) fell 28.7% to $0.0459. LumiraDx agreed to sell its point-of-care technology platform to Roche.
- Corcept Therapeutics Incorporated (NASDAQ: CORT) fell 26.3% to $23.93 after the company announced the Court for the District of New Jersey issued a decision that Teva Pharmaceuticals does not infringe any asserted claims of Corcept's U.S. Patents 10,195,214 and 10,842,800.
- Anavex Life Sciences Corp. (NASDAQ: AVXL) shares fell 26.2% to $6.88 after the company provided an update on Rett Syndrome program.
- Mobix Labs, Inc. (NASDAQ: MOBX) fell 25.6% to $2.9895.
- FLJ Group Limited (NASDAQ: FLJ) shares fell 21% to $1.58 after surging 48% on Friday.
- Aditxt, Inc. (NASDAQ: ADTX) shares fell 21% to $5.24 after jumping around 38% on Friday.
- Vertex Energy, Inc. (NASDAQ: VTNR) declined 20.1% to $2.7069 after the company announced it amended its existing term loan agreement, which provides for an incremental $50 million in borrowings to the company.
- Vast Renewables Limited (NASDAQ: VSTE) fell 17.2% to $4.14.
- JOYY Inc. (NASDAQ: YY) fell 16.2% to $33.27 after the company announced it received a written notice from an affiliate of Baidu purporting to terminate the Share Purchase Agreement, dated Nov. 16, 2020.
- GoodRx Holdings, Inc. (NASDAQ: GDRX) dipped 15.5% to $5.66 after B of A Securities downgraded the stock from Buy to Underperform and lowered its price target from $8 to $4.5.
- China Green Agriculture, Inc. (NYSE: CGA) shares fell 15.2% to $2.57 after jumping over 59% on Friday.
- KORE Group Holdings, Inc. (NYSE: KORE) shares fell 13.8% to $0.8451 after jumping over 40% on Friday.
- Aurora Innovation, Inc. (NASDAQ: AUR) fell 13.8% to $3.7605 after the company filed for an $850 million mixed securities shelf offering.
- ToughBuilt Industries, Inc. (NASDAQ: TBLT) declined 13.5% to $8.86.
- Bitdeer Technologies Group (NASDAQ: BTDR) fell 12.5% to $8.63.
- Amprius Technologies, Inc. (NYSE: AMPX) fell 11.5% to $4.68.
- PureTech Health plc (NASDAQ: PRTC) fell 9.6% to $24.79.
- Rivian Automotive, Inc. (NASDAQ: RIVN) dipped 9.1% to $21.34 after the company reported delivery and production figures for 2023.
- Fisker Inc. (NYSE: FSR) fell 7.7% to $1.6141.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Now Read This: Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.